• Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance — VISION Network, 10 States, August 2021–January 2022 Cite CITE Title : Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance — VISION Network, 10 States, August 2021–January 2022 Personal Author(s) : Thompson, Mark G.;Natarajan, Karthik;Irving, Stephanie A.;Rowley, Elizabeth A.;Griggs, Eric P.;Gaglani, Manjusha;Klein, Nicola P.;Grannis, Shaun J.;DeSilva, Malini B.;Stenehjem, Edward;Reese, Sarah E.;Dickerson, Monica;Naleway, Allison L.;Han, Jungmi;Konatham, Deepika;McEvoy, Charlene;Rao, Suchitra;Dixon, Brian E.;Dascomb, Kristin;Lewis, Ned;Levy, Matthew E.;Patel, Palak;Liao, I-Chia;Kharbanda, Anupam B.;Barron, Michelle A.;Fadel, William F.;Grisel, Nancy;Goddard, Kristin;Yang, Duck-Hye;Wondimu, Mehiret H.;Murthy, Kempapura;Valvi, Nimish R.;Arndorfer, Julie;Fireman, Bruce;Dunne, Margaret M.;Embi, Peter;Azziz-Baumgartner, Eduardo;Zerbo, Ousseny;Bozio, Catherine H.;Reynolds, Sue;Ferdinands, Jill;Williams, Jeremiah;Link-Gelles, Ruth;Schrag, Stephanie J.;Verani, Jennifer R.;Ball, Sarah;Ong, Toan C.; Corporate Authors(s) : CDC COVID-19 Response Team.;Columbia University. Department of Biomedical Informatics.;New York Presbyterian Hospital.;Center for Health Research (Kaiser-Permanente Medical Care Program. Northwest Region);Texas A&M University College of Medicine. Baylor Scott & White Health.;Kaiser Permanente Vaccine Study Center.;Regenstrief Institute for Health Care‏. Center for Biomedical Informatics.;Indiana University. Richard M. Fairbanks School of Public Health.;HealthPartners Institute.;Intermountain Healthcare (Utah). Division of Infectious Diseases and Clinical Epidemiology.;University of Colorado Anschutz Medical Campus. Department of Medicine.;Indiana University. Fairbanks School of Public Health;Children’s Minnesota (Minneapolis, Minnesota;Vanderbilt University.;VISION Network.; Published Date : January 21, 2022 Series : MMWR. Morbidity and mortality weekly report ; v. 71, early release, January 21, 2022 URL : https://stacks.cdc.gov/view/cdc/113718 File Format: Copy Export RIS [PDF - 417.21 KB] Personal Author: Thompson, Mark G. ; Natarajan, Karthik ; ... January 21, 2022 | MMWR. Morbidity and mortality weekly report ; v. 71, early release, January 21, 2022 Description: What is already known about this topic? COVID-19 mRNA vaccine effectiveness (VE) in preventing COVID-19 might decline because of waning of vaccine-ind... File Type: [PDF - 417.21 KB] File Type: [PDF - 417.21 KB] Addendum: Considerations for conducting rapid community assessment in tribal communities Cite CITE Title : Addendum: Considerations for conducting rapid community assessment in tribal communities Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : November 2021 Series : Vaccinate with confidence URL : https://stacks.cdc.gov/view/cdc/113700 File Format: Copy Export RIS [PDF - 990.82 KB] Corporate Authors: Centers for Disease Control and Prevention (U.S.) November 2021 | Vaccinate with confidence Description: This document outlines considerations and guidelines for working with Tribal Communities as part of a Rapid Community Assessment (RCA).CDC-RCA-Guide-T... File Type: [PDF - 990.82 KB] File Type: [PDF - 990.82 KB] COVID-19 vaccine confidence rapid community assessment guide : a guide to help you understand your community’s needs regarding COVID-19 vaccines in three weeks Cite CITE Title : COVID-19 vaccine confidence rapid community assessment guide : a guide to help you understand your community’s needs regarding COVID-19 vaccines in three weeks Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : October 2021 Series : Vaccinate with confidence URL : https://stacks.cdc.gov/view/cdc/113701 File Format: Copy Export RIS [PDF - 2.75 MB] Corporate Authors: Centers for Disease Control and Prevention (U.S.) October 2021 | Vaccinate with confidence Description: This rapid community assessment (RCA) guide is for staff of state, territorial, local, and tribal health departments involved in various aspects of CO... File Type: [PDF - 2.75 MB] File Type: [PDF - 2.75 MB] Addendum : Considerations for conducting rapid community assessment in adolescent populations and digital contexts Cite CITE Title : Addendum : Considerations for conducting rapid community assessment in adolescent populations and digital contexts Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : November 2021 Series : Vaccinate with confidence URL : https://stacks.cdc.gov/view/cdc/113699 File Format: Copy Export RIS [PDF - 898.96 KB] Corporate Authors: Centers for Disease Control and Prevention (U.S.) November 2021 | Vaccinate with confidence Description: This document outlines considerations and guidelines for working with adolescent populations (12–17 years old) and gathering information from digita... File Type: [PDF - 898.96 KB] File Type: [PDF - 898.96 KB] Di(2-etilhexil) ftalato (DEHP) Cite CITE Title : Di(2-etilhexil) ftalato (DEHP) Corporate Authors(s) : United States. Agency for Toxic Substances and Disease Registry. Published Date : Septiembre 2002 Series : ToxFAQs URL : https://stacks.cdc.gov/view/cdc/113702 File Format: Copy Export RIS [PDF - 269.77 KB] Corporate Authors: United States. Agency for Toxic Substances and Disease Registry. Septiembre 2002 | ToxFAQs Description: Esta hoja informativa contesta las preguntas más frecuentes acerca de los efectos del di(2-etilhexil)ftalato (DEHP) sobre la salud. Para más infor... File Type: [PDF - 269.77 KB] File Type: [PDF - 269.77 KB] Di(2-ethylhexyl)phthalate (DEHP) - ToxFAQs Cite CITE Title : Di(2-ethylhexyl)phthalate (DEHP) - ToxFAQs Corporate Authors(s) : United States. Agency for Toxic Substances and Disease Registry. Office of Innovation and Analytics. Toxicology Section. Published Date : January 2022 Series : ToxFAQs URL : https://stacks.cdc.gov/view/cdc/113703 File Format: Copy Export RIS [PDF - 154.25 KB] Corporate Authors: United States. Agency for Toxic Substances and Disease Registry. Office of Innovation and Analytics. Toxicology Section. January 2022 | ToxFAQs No Description File Type: [PDF - 154.25 KB] File Type: [PDF - 154.25 KB]

More +